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Summary The transplantable pregnancy-dependent mammary tumour (TPDMT-4), the related hormone-
dependent (TPDMT-4EP) and autonomous (T4-OI320 and T4-OI96) subline tumours, and the mammary
glands from DDD mice were compared for angiogenic activity on the rabbit cornea by tissue implantation.
The TPDMT-4EP tumour was established by serially transplanting TPDMT-4 tumour fragments in oestradiol
plus progesterone treated mice. The T4-01320 and T4-0196 tumours directly derived from the TPDMT-4 and
TPDMT-4EP tumours, respectively. Angiogenic activity was graded by macroscopic and microscopic
examinations into 3 classes; negative, partial and complete angiogenesis. These tumours were comparable to
mammary glands in activity and induced complete angiogenesis in only 15-23% of the implants. However,
when partial and complete responses were combined as positive angiogenesis, TPDMT-4, T4-01320, TPDMT-
4EP and T4-OI96 tumour implants were angiogenic in 25, 29, 42 and 54%, respectively. The T4-0196 tumour
was significantly more angiogenic than the parent tumour but this was not so for the TPDMT-4EP tumour.
Spontaneous C3H mouse mammary tumours, human gliomas from nude mice, rat Walker 256 carcinomas
and rabbit VX-2 tumours induced complete angiogenesis in 54, 63, 59 and 92% of the implants, respectively.
The results suggest that the TPDMT-4 tumour is unique in being weakly angiogenic and able to progress
toward greater autonomy with or without augmented angiogenic activity in different conditions.
Neovascularization or the formation of new blood
vessels occurs during a variety of biological
processes such as embryonic development, wound
healing, inflammation and neoplasia. In particular,
the growth of neoplastic cells is considered to
depend on the supply of nutriment and oxygen and
on the elimination of metabolic waste through new
blood vessels arising from the host capillaries.
Previous studies (Folkman, 1985; Gullino, 1981)
indicated that most if not all malignant solid
tumours have the ability to induce angiogenesis.
Gimbrone and Gullino (1976a) further demon-
strated that hyperplastic alveolar nodules
considered as a preneoplastic lesion also elicited the
activity on the rabbit iris and that the capacity to
evoke neovascularization was acquired during
malignant transformation of mouse mammary
tissue. They proposed that the property may be
useful for identification of populations of
intermediate cells at high risk for neoplastic trans-
formation. Strum (1983) presented a similar report
indicating that the angiogenesis-positive response
on the chorioallantoic membrane of chick embryo
correlated directly with the neoplastic potential of
the tissues including mammary gland and various
outgrowths from GR mice. In addition, Tapper et
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al. (1979) observed that neoplastic cells in vivo
released angiogenic factors into the surrounding
fluid or the aqueous tumour in patients with retino-
blastoma. Although considerable information is
available on tumour angiogenesis (Weiss et al.,
1979; Fenselau et al., 1981; Gullino, 1981;
Alessandri et al., 1983; Raju et al., 1984; Fett et al.,
1985; Folkman, 1985), the mechanism remains to
be elucidated.
A transplantable pregnancy-dependent mouse
mammary tumour line, TPDMT-4, was established
from a spontaneous tumour in DDD mice and has
served as a model for experimental study of the
endocrine therapy of breast cancer (Matsuzawa,
1982). Although TPDMT-4 tumours are notable
for their stable hormone dependence, they progress
to hormone-responsive or autonomous tumours
at different rates under varying conditions
(Matsuzawa et al., 1983). The current investigation
was conducted to elucidate whether angiogenic
activity is enhanced during progression toward
autonomy, a more malignant state, in this model
system.
Materials and methods
Normal and tumour tissues
TPDMT-4, TPDMT-4EP, T4-01320 and T4-0196
tumours were were assayed in the growth phase at
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transplant generations 9, 52, 22, and 46,
respectively. The TPDMT-4 is a pregnancy-
dependent tumour characterized by growth during
pregnancy and regression after delivery in breeders
as well as practically no growth in virgins
(Matsuzawa, 1982). The tumour behaves like a
preneoplastic lesion in the clear fat pads of virgin
mice (Matsuzawa et al., 1982). Tumours were
obtained from late-pregnant hosts and used for
assay. The TPDMT-4EP tumour is a hormone-
dependent subline established by passaging
TPDMT-4 tissue from generation 8 through female
mice carrying an s.c. hormone pellet containing
oestradiol and progesterone (Masuzawa et al.,
1983). The tumourigenic potential of the subline in
virgins is higher than that of the parent tumour.
Tumours were obtained from such hormone-treated
hosts and used for assay. The T4-01320 tumour is
another subline originating in an outgrowth in
virgins from enzymatically dispersed TPDMT-4
cells at generation 17. The T4-0196 tumour is a
subline, which was established from an outgrowth
of TPDMT-4EP tissue at generation 28 in virgin
mice (Matsuzawa et al., 1983). The last 2 sublines
were autonomous tumours characterized by similar
growth rates in virgin and ovariectomized mice,
although T4-0196 tumours grow more rapidly than
T4-OI320 ones. These autonomous tumours were
serially transplanted in virgins and used for assay.
TPDMT-4 and TPDMT-4EP tumours have both
oestrogen and progesterone receptors, consistent
with their hormonal requirement for growth, T4-
01320 has oestrogen but not progesterone receptors,
and T4-0196 lacks both receptors. Resting
mammary glands from virgin and active ones from
pregnant DDD mice, spontaneous mammary
tumours from C3H mice, Walker 256 carcinomas
from rats, human gliomas multiforme TMIMS-583
(Tanaka et al., 1982) from nude mice, and VX-2
tumours from Japanese white rabbits were included
for comparison.
For angiogenesis assay tumour fragments without
visible necrosis were cut out from the cortical area.
When the fragments thus prepared from mouse
mammary tumours were dissociated with enzymes
as described by DeOme et al. (1978), the resultant
cells were found to be 80-95% viable by trypan
blue exclusion. In addition, the fragments gave rise
to 100% tumours in appropriate conditions in
syngeneic hosts.
Bioassayfor angiogenesis
Angiogenic activity was assayed by implanting a
tissue fragment (1.5mm3) into the rabbit cornea as
described by Gullino (1981). Male Japanese white
rabbits weighing - 2.5kg were anaesthesized by
i.v. injection of pentobarbital (25mgkg-1),
supplemented with topical application of a few
drops of 0.4% oxybuprocaine, an ophthalmic
surface anaesthetic (Santen Pharmaceutical Co.
Ltd., Osaka, Japan). The eye-ball was moved
forward, fixed with forceps and covered around
with a sheet of rubber. A 2mm incision was made
at the centre of the normally avascular cornea to
about one-half the thickness of it with a Feather
blade No. FA-1O (Feather Industries, Ltd., Osaka,
Japan). An iris spatula 2mm in width was inserted
into the cornea stroma to make an oblong pocket.
The peripheral pocket ended at -1.5mm from the
limbus, the sclerocorneal margin. A test tissue
fragment was deposited at the bottom of the pocket
and the open border of the pocket was sealed by
gentle pressure with the spatula. The procedure was
performed under sterile conditions. The cornea was
observed, photographed, excised and fixed in
phosphate-buffered 10% formalin solution for
histology on day 10 of implantation, since
practically no difference in angiogenic response was
observed on days 7-10. A strip -Imm in width,
which contained the graft and the proximate
limbus, was cut out from the fixed cornea,
processed routinely, sectioned serially at 7pm and
stained with hematoxylin and eosin for histology.
Some of the tumour fragments before assay were
also examined histologically for infiltrating host
cells. These histological examinations were
conducted independently and blind.
Evaluation ofangiogenesis
Corneas which provided clear histological evidence
of inflammatory responses were excluded. The
angiogenic responses of the corneas to the grafted
tissues were evaluated by macroscopic observation
of the live system, review of the photographs and
microscopic observation of the histological sections.
Angiogenic activity was graded into three categories
according to the following criteria: complete
angiogenesis, newly formed vessels reaching the
graft in both macroscopic and microscopic obser-
vations (Figure 1a, b); partial angiogenesis, new
vessels sprouting from the limbus and reaching the
middle but not the graft macroscopically and
microscopically; and negative angiogenesis, in
which neovascularization was macroscopically and
microscopically insignificant.
Statistics
All data were analysed by Fisher's exact test, and
the difference was considered as significant at
P<0.05 (Dixon, et al., 1969).MOUSE MAMMARY TUMOUR AND ANGIOGENESIS
Figure 1 Macrograph (a, x 3.5) and micrograph (b, x 75) showing complete angiogenesis in rabbit cornea 10
days after implantation of mammary tumour. Note widespread development of dense and structured network
of blood vessels growing toward the implanted tumour (T) from the limbus (L) and absence of inflammatory
reaction. F, filament of the stereomicroscope lamp.
Results
The pooled results of the angiogenesis assays with
normal and various tumour tissues are summarized
in Table I. When angiogenic activity was evaluated
by the criterion of complete angiogenesis charac-
terized by new blood vessels reaching the grafts,
spontaneous C3H mouse mammary tumours, rat
Walker carcinomas, human gliomas grown in nude
mice and rabbit VX-2 tumours which were included
as positive controls because of their reputedly high
angiogenic activity, all displayed significantly
greater levels of angiogenesis compared with virgin
mammary glands. The angiogenesis rates, defined
as the percentage of grafts eliciting complete angio-
genesis, were 54, 59, 63 and 92%, respectively, for
these tumours. In contrast, the pregnancy-dependent
mouse mammary tumour, TPDMT-4, the hormone-
dependent subline, TPDMT-4EP, and the autono-
mous sublines. T4-01320 and T4-0196, were all
weakly angiogenic and not significantly different
from each other or from virgin mammary gland,
the angiogenesis rate being 15-23% in these
tumours.
In order to clarify the relationship between
angiogenic activity and tumour progression from
dependence to autonomy in the TPDMT-4 system,
the criterion of partial angiogenesis, characterized
by new vessels growing midway to the graft but not
reaching it, was also adopted in a further analysis.
The angiogenesis rates expressed as the percentage
of partially and completely angiogenic grafts were:
TPDMT-4EP (42%), T4-0196 (54%) and TPDMT-
4 (25%). The TPDMT-4EP tumour was a subline
of the TPDMT-4 which was more tumourigenic in
virgins (Matsuzawa et al., 1983). These results
taken together indicated that the TPDMT-4 tumour
had acquired more angiogenic activity in the course
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Table I Angiogenesis activity of various tissues on the rabbit cornea
Number of Number(%) ofgrafts
corneal producing angiogenesis
Stage Number grafts
Tissues Hosta ofgrowth ofdonors assayed Negative Partial Complete
Mammary tumours
TPDMT-4 DDD mice, LP growing 3 20 15(75) 2(10) 3(15)
TPDMT-4EP DDD mice, HT growing 4 31 18(58) 6(19) 7(23)
T4-OI320 DDD mice, V growing 5 21 15(71) 2(10) 4(19)
T4-0196 DDD mice, V growing 4 26 12(46) 9(35) 5(19)
Spontaneous C3H mice growing 4 24 9(38) 2 (8) 13(54)
Normal mammary DDD mice, V resting 3 27 20(74) 2 (7) 5(19)
gland DDD mice, LP growing 4 26 14(54) 2 (8) 10(38)
Human glioma nude mice growing 2 19 4(21) 3(16) 12(63)
Rat Walker 256 Wistar rat growing 3 17 7(41) 0 (0) 10(59)
VX-2 Rabbit growing 8 51 4 (8) 0 (0) 47(92)
aLP-late pregnancy, HT-hormone-treated, V-virgin.
of progression to greater malignancy under
continuous hormonal stimulation. On the other
hand, the angiogenesis rate was similar in TPDMT-
4 and the autonomous subline, T4-01320, as well as
in TPDMT-4EP and its autonomous subline, T4-
0196, indicating that the dependent tumours could
progress toward autonomy without augmented
angiogenic activity.
It is known that a variety of normal cells
including macrophages and lymphocytes can induce
angiogenesis (Folkman, 1985). Histologically,
however, leucocytes accounted for 6-12% of cells in
the tumour fragments used for assay (data not
shown) and showed no significant difference in
content among the mouse mammary tumours
assayed. Thus, it was impossible to impute the
difference in angiogenic activity solely to their
leucocyte content.
Developing mammary glands from pregnant mice
appeared to be more angiogenic than those from
virgins, although the difference in angiogenesis rate
was insignificant. It was noted in the former that
complete angiogenesis was mostly associated with
glanulomatous changes. Thus, the responses
induced by mammary glands from pregnant
animals appeared to be different from those seen
with the other test specimens.
Discussion
Although exceptionally stable in hormone depen-
dence, TPDMT-4 mouse mammary tumours have
progressed gradually so as to grow at lower
hormone levels during serial transplantation
(Matsuzawa, 1982). In addition, their progression
to autonomy was enhanced by continuous stimu-
lation with hormones (Matsuzawa et al., 1983) or
by enzymatic dissociation (Matsuzawa et al.,
unpublished). As a result, a number of sublines,
hormone-dependent, ovarian-dependent and auto-
nomous, have been established and used for
elucidation of the mechanism of tumour pro-
gression (Matsuzawa, 1982).
In the current study, the parent line, TPDMT-4,
a hormone-dependent subline, TPDMT-4EP, and
autonomous sublines, T4-01320 and T4-0196 were
examined for angiogenic ability to clarify whether
this property plays a significant role in tumour
progression. As shown in Table I, TPDMT-4 and
T4-01320 tumours evoked weak angiogenic re-
sponses as did normal virgin mammary glands. In
contrast, TPDMT-4EP and T4-0196 tumours had
rather higher angiogenic potential as demonstrated
by the greater proportion of partially and
completely angiogenic grafts. The potential was
similar in both tumours. TPDMT-4EP tumours
were obtained after transplanting TPDMT-4
fragments over many generations in the continuous
presence of oestradiol and progesterone, and they
had higher tumourigenic potential in virgins than
the parent tumours (Mastuzawa et al., 1983). The
autonomous sublines, T4-OI320 and T4-0196, were
established by single passage through virgin mice of
enzymatically dissociated free TPDMT-4 cells and
TPDMT-4EP tumour fragments, respectively.
Together these results suggest that TPDMT-4
tumour cells might have acquired more angiogenic
activity with progression to more autonomous
states under the influence of hormones and that
progression from dependent to independent states
may occur with or without augmented angiogenic
potential. Selection of highly pre-existing angiogenic
cells in the parent tumour is an implausibleMOUSE MAMMARY TUMOUR AND ANGIOGENESIS 95
explanation, since the autonomous sublines were
isolated in the same endocrine environment. The
low angiogenic responses observed do not accord
with the finding that most solid tumours including
human and murine mammary tumours are highly
angiogenic (Gimbrone & Gullino, 1976a, b; Gullino,
1977; Brem et al., 1978). The disparity is not
attributable to the techniques applied, since spon-
taneous C3H mouse mammary tumours (Gimbrone
& Gullino, 1976a,b), and rat Walker 256
carcinomas (Weiss et al., 1979), which have been
proved to possess strong angiogenic potency by
different assay methods, and human gliomas and
rabbirVX-2 tumours evoked significant angiogenic
responses under the present assay conditions (Table
I). However, examples of angiogenesis-negative
neoplastic cells include tissue culture lines of human
melanoma (Stenzinger et al., 1983) and glioma
(Matsuno, 1981). Nevertheless, the sensitivity of the
assay method should be taken into account in
interpretation of the present data, since the rabbit
corneal assay is 100 times less sensitive than the
chick embryo chorioallantoic membrane assay
utilizing the purified angiogenic substance,
angiogenin (Fett et al., 1985).
On the other hand, it is conceivable that the
avascular cornea in which the test tissue grafts were
implanted might not be favourable for the
production of angiogenic factors by hormone-
dependent cells due to an insufficient supply of
hormones. It is, however, difficult to explain on this
assumption why C3H mouse mammary tumours
and T4-0196 but not T4-01320 tumours induced
neovascularization in spite of their similar
autonomous growth characteristics in syngeneic
hosts. The more extensive angiogenesis induced by
T4-0196 than T4-OI320 tumours suggests that
angiogenic activity may play a role in tumour
growth, since the former grew more rapidly with a
shorter latency period than the latter under the
same conditions.
This study has led to the conclusion that
TPDMT-4 tumours are unique in their low
angiogenic activity and can progress toward less
hormone dependence or autonomy with or without
augmentation of the activity. In the GR mouse
mammary system, Strum (1983) observed
augmented angiogenesis activity along with
transition from dependent to independent or
autonomous states using the chorioallantoic
membrane assay. Therefore, the idea remains to be
further confirmed by this assay and other
angiogenesis tests utilizing mouse dermis (Kaminski
et al., 1983), endothelial cell migration in vitro
(Alessandri et al., 1983; Raju et al., 1984), and
direct radioimmunoassay of angiogenic factors
(Shahabuddin et al., 1985).
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